Clinical Trials in Houston

Showing 5861-5880 of 17,885 trials

Safety and Immunogenicity of CHIKV VLP Vaccine PXVX0317 in Adults ≥65 Years

NCT05349617

The purpose of this phase 3, randomized, double-blind, placebo-controlled study is to evaluate the safety and immunogenicity to PXVX0317 in adults ≥65 years of age.

Chikungunya Virus

Bavarian Nordic413 participantsStarted May 2022

Miami, Florida, United States • Miami Lakes, Florida, United States • St. Petersburg, Florida, United States +7 more locations

COMPLETEDPhase 3< 1 mile

Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute Schizophrenia

NCT00254202

The purpose of this study is to determine the safety and efficacy of iloperidone compared to placebo and an active comparator in the treatment of patients with schizophrenia in acute exacerbation.

Schizophrenia

Vanda Pharmaceuticals593 participantsStarted Nov 2005

Little Rock, Arkansas, United States • Anaheim, California, United States • Cerritos, California, United States +39 more locations

Safety and Immunogenicity of CHIKV VLP Vaccine PXVX0317 in Adults ≥65 Years

Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute Schizophrenia

Find Trials by Condition in Houston

Garadacimab Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary Fibrosis

Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer

Salud en Mis Manos - Breast and Cervical Cancer Prevention and Early Detection - Expansion 2

Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy

Fludarabine, Cytarabine, and Pegcrisantaspase for the Treament of Relapsed or Refractory Leukemia

Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi

Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)

Osia 2 Pediatric Expansion Study

Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL)

Comprehensive Outcomes for After Cancer Health

Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Retinal Vein Occlusion

A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis

Biomarkers to Predict Time to Plasma HIV RNA Rebound

Erlotinib Versus Oral Etoposide in Patients With Recurrent or Refractory Pediatric Ependymoma

Study of ATH434 in Participants with Multiple System Atrophy

Risk of Recurrent CeAD After Pregnancy

Motion Syros: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness

Multicenter Evaluation of Near Vision and Outdoor Time in Kids Study